Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Otsuka Holdings CoTSE:4578 +2.20%90 EV-to-FCF is 21.27 as of Jul. 25, 2026, which is 4% above its 10-year median of 20.45. GuruFocus rates TSE:4578 with a GF Score™ of 90/100 and a GF Value™ of 円8,384.31 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 568 Drug Manufacturers companies, Otsuka Holdings Co ranks better than 50% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Otsuka Holdings Co's Enterprise Value is 円5,556,356 Mil.
Otsuka Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円261,191 Mil. Therefore, Otsuka Holdings Co's EV-to-FCF for today is 21.27.
The historical rank and industry rank for Otsuka Holdings Co's EV-to-FCF or its related term are showing as below:
TSE:4578'
s EV-to-FCF Range Over the Past 10 Years
Min: -331.99 Med: 20.45 Max: 142.53
Current: 20.96
During the past 13 years, the highest EV-to-FCF of Otsuka Holdings Co was 142.53. The lowest was -331.99. And the median was 20.45.
TSE:4578's EV-to-FCF is ranked better than 50% of 568
companies
in the Drug Manufacturers industry
Industry Median: 21.015
vs TSE:4578: 20.96
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Otsuka Holdings Co (TSE:4578) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Otsuka Holdings Co's PE Ratio (TTM) for today is calculated as:
Otsuka Holdings Co's share price for today is 円11155.00.
Otsuka Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円712.800.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Otsuka Holdings Co EV-to-FCF Related Terms
Otsuka Holdings Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Otsuka Holdings Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otsuka Holdings Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Otsuka Holdings Co's EV-to-FCF falls into.
Otsuka Holdings Co's current Enterprise Value is 円5,556,356 Mil.
Otsuka Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円261,191 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otsuka Holdings Co (TSE:4578) has a EV-to-FCF of 21.27 as of Jul. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Otsuka Holdings Co and its competitors. This is near median its historical median of 20.45. According to the industry distribution chart, Otsuka Holdings Co ranks #284 out of 568 companies in the Drug Manufacturers industry, placing it in the top 50%.
Is Otsuka Holdings Co's EV-to-FCF too high?
Otsuka Holdings Co's current EV-to-FCF of 21.27 is near median its 10-year median of 20.45. The Drug Manufacturers industry median EV-to-FCF is 21.02. Otsuka Holdings Co's value of 21.27 is 1.2% above this industry median. Based on the distribution chart, Otsuka Holdings Co ranks #284 out of 568 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Otsuka Holdings Co has a GF Score™ of 90/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's EV-to-FCF compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Otsuka Holdings Co ranks #284 out of 568 companies for EV-to-FCF. This puts Otsuka Holdings Co in the upper half of its industry. The industry median EV-to-FCF is 21.02. Otsuka Holdings Co's value of 21.27 is 1.2% above this benchmark. While the company's 10-year median is 20.45 vs. the industry median of 21.02, Otsuka Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.02, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otsuka Holdings Co's current EV-to-FCF of 21.27 is 1.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Otsuka Holdings Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otsuka Holdings Co's current EV-to-FCF is 21.27, which is near median its own 10-year median of 20.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (TSE:4578) is currently considered Significantly Overvalued. The stock's GF Value™ is 円8,384.31, compared to a current price of 円11,155.00 — trading 33% above its estimated fair value. The current EV-to-FCF is 21.27, which is near median its 10-year median of 20.45 and 1.2% above the Drug Manufacturers industry median of 21.02. Otsuka Holdings Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Otsuka Holdings Co (TSE:4578), the current EV-to-FCF is 21.27 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Otsuka Holdings Co (TSE:4578) Overvalued in 2026?
Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued.
The current stock price of 円11,155.00 is trading 33% above its estimated GF Value™ of 円8,384.31.
GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4578:
EV-to-FCF: 21.27 (near median its 10-year median of 20.45)
GF Value™: 円8,384.31 vs. price of 円11,155.00 (33% above fair value)
Industry Position: 1.2% above the Drug Manufacturers median (#284 of 568)
No single metric tells the full story. See the TSE:4578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
90GF Score
Get the complete analysis for TSE:4578
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4578 has been successfully added to your 
